jueves, 19 de noviembre de 2026
Three Antidepressants Show Superior Sustained Response in Major Depression
https://www.medscape.com/viewarticle/three-antidepressants-show-superior-sustained-response-major-2026a10018px?ecd=WNL_trdalrt_pos1_ous_261119_etid8918857&uac=148436CN&impID=8918857
A large comparative study of antidepressant medication has identified the drugs’ ability to achieve and sustain improvements in patients with major depressive disorder (MDD).
The analysis showed that escitalopram, duloxetine, and agomelatine were associated with higher rates of sustained treatment response than those observed with fluoxetine. Escitalopram and duloxetine were also associated with lower rates of treatment discontinuation.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario